Co-administration of IL3 with G-CSF increases the CFU-S mobilization into peripheral blood

Int J Hematol. 1995 Aug;62(2):75-82. doi: 10.1016/0925-5710(95)00386-7.

Abstract

In an attempt to establish an efficient method of collecting peripheral blood stem cells and to utilize them for allogeneic peripheral blood stem cell transplantation, the effect of a combined administration of recombinant murine interleukin-3 (IL3) and recombinant human granulocyte colony-stimulating factor (G-CSF) to mobilize bone marrow stem cells into the circulation was examined in C57BL/6 mice. Some appreciable numbers (796 +/- 112/ml) of CFU-GM were recovered 6 days after G-CSF administration (500 micrograms/kg per day), while by IL3 administration (100,000 units/kg per day), the CFU-GM count was much lower (61 +/- 9/ml) with a small peak at day 4. By a combined administration of IL3 (100,000 units/kg per day) and G-CSF (500 micrograms/kg per day), the CFU-GM count at the peak of day 5 was significantly augmented (1178 +/- 277/ml) as compared to that of G-CSF or IL3 alone (P < 0.05). The CFU-S counts at day 5 (168 +/- 12/ml) and at day 6 (172 +/- 27) were also significantly higher than those of IL3 alone (day 5, 30 +/- 15/ml; day 6, 20 +/- 10/ml) or G-CSF alone (day 5, 114 +/- 14/ml; day 6, 112 +/- 19/ml). Thus the combined administration of IL3 and G-CSF appears to be promising for high yield collection of peripheral blood stem cells.

MeSH terms

  • Animals
  • Blood Cell Count / drug effects
  • Bone Marrow / drug effects
  • Bone Marrow Cells
  • Cell Count / drug effects
  • Colony-Forming Units Assay
  • Drug Synergism
  • Female
  • Granulocyte Colony-Stimulating Factor / administration & dosage*
  • Granulocyte Colony-Stimulating Factor / pharmacology
  • Granulocyte Colony-Stimulating Factor / therapeutic use
  • Hematopoietic Cell Growth Factors / pharmacology
  • Hematopoietic Cell Growth Factors / therapeutic use*
  • Hematopoietic Stem Cells / drug effects*
  • Humans
  • Interleukin-3 / administration & dosage*
  • Interleukin-3 / pharmacology
  • Interleukin-3 / therapeutic use
  • Mice
  • Mice, Inbred C57BL
  • Recombinant Proteins / pharmacology
  • Spleen / cytology
  • Spleen / drug effects

Substances

  • Hematopoietic Cell Growth Factors
  • Interleukin-3
  • Recombinant Proteins
  • Granulocyte Colony-Stimulating Factor